Saturday, 11 February 2017

In-Depth Research on Global Remicade Biosimilar Sales Market 2017

Global Remicade Biosimilar Sales Market Report 2017 is a new market research publication announced by Reportstack. This report studies sales (consumption) of Remicade Biosimilar in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering 
Teva Pharmaceutical Industries 
Synthon Pharmaceuticals 
LG Life Sciences 
Novartis (Sandoz) 
Celltrion 
Biocon 
Hospira 
Merck Serono (Merck Group) 
Biogen idec Inc. 
Genentech (Roche Group)
Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Remicade Biosimilar in these regions, from 2011 to 2021 (forecast), like 
United States 
China 
Europe 
Japan 
Southeast Asia 
India 
Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into 
100mg/10ml 
500mg/50ml 
Split by applications, this report focuses on sales, market share and growth rate of Remicade Biosimilar in each application, can be divided into 
Blood Disorders 
Oncology Diseases
Snapshot of TOC with Companies Mentioned
9 Global Remicade Biosimilar Manufacturers Analysis 
9.1 Teva Pharmaceutical Industries 
9.1.1 Company Basic Information, Manufacturing Base and Competitors 
9.1.2 Remicade Biosimilar Product Type, Application and Specification 
9.1.2.1 100mg/10ml 
9.1.2.2 500mg/50ml 
9.1.3 Teva Pharmaceutical Industries Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017) 
9.1.4 Main Business/Business Overview 
9.2 Synthon Pharmaceuticals 
9.2.1 Company Basic Information, Manufacturing Base and Competitors 
9.2.2 Remicade Biosimilar Product Type, Application and Specification 
9.2.2.1 100mg/10ml 
9.2.2.2 500mg/50ml 
9.2.3 Synthon Pharmaceuticals Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017) 
9.2.4 Main Business/Business Overview 
9.3 LG Life Sciences 
9.3.1 Company Basic Information, Manufacturing Base and Competitors 
9.3.2 Remicade Biosimilar Product Type, Application and Specification 
9.3.2.1 100mg/10ml 
9.3.2.2 500mg/50ml 
9.3.3 LG Life Sciences Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017) 
9.3.4 Main Business/Business Overview 
9.4 Novartis (Sandoz) 
9.4.1 Company Basic Information, Manufacturing Base and Competitors 
9.4.2 Remicade Biosimilar Product Type, Application and Specification 
9.4.2.1 100mg/10ml 
9.4.2.2 500mg/50ml 
9.4.3 Novartis (Sandoz) Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017) 
9.4.4 Main Business/Business Overview 
9.5 Celltrion 
9.5.1 Company Basic Information, Manufacturing Base and Competitors 
9.5.2 Remicade Biosimilar Product Type, Application and Specification 
9.5.2.1 100mg/10ml 
9.5.2.2 500mg/50ml 
9.5.3 Celltrion Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017) 
9.5.4 Main Business/Business Overview 
9.6 Biocon 
9.6.1 Company Basic Information, Manufacturing Base and Competitors 
9.6.2 Remicade Biosimilar Product Type, Application and Specification 
9.6.2.1 100mg/10ml 
9.6.2.2 500mg/50ml 
9.6.3 Biocon Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017) 
9.6.4 Main Business/Business Overview 
9.7 Hospira 
9.7.1 Company Basic Information, Manufacturing Base and Competitors 
9.7.2 Remicade Biosimilar Product Type, Application and Specification 
9.7.2.1 100mg/10ml 
9.7.2.2 500mg/50ml 
9.7.3 Hospira Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017) 
9.7.4 Main Business/Business Overview 
9.8 Merck Serono (Merck Group) 
9.8.1 Company Basic Information, Manufacturing Base and Competitors 
9.8.2 Remicade Biosimilar Product Type, Application and Specification 
9.8.2.1 100mg/10ml 
9.8.2.2 500mg/50ml 
9.8.3 Merck Serono (Merck Group) Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017) 
9.8.4 Main Business/Business Overview 
9.9 Biogen idec Inc. 
9.9.1 Company Basic Information, Manufacturing Base and Competitors 
9.9.2 Remicade Biosimilar Product Type, Application and Specification 
9.9.2.1 100mg/10ml 
9.9.2.2 500mg/50ml 
9.9.3 Biogen idec Inc. Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017) 
9.9.4 Main Business/Business Overview 
9.10 Genentech (Roche Group) 
9.10.1 Company Basic Information, Manufacturing Base and Competitors 
9.10.2 Remicade Biosimilar Product Type, Application and Specification 
9.10.2.1 100mg/10ml 
9.10.2.2 500mg/50ml 
9.10.3 Genentech (Roche Group) Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017) 
9.10.4 Main Business/Business Overview
Contact:
Debora White
Manager - Marketing
Ph: +1-888-789-6604
ReportstackMarket Research
###
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)